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Division of Reproductive Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom Implantation in humans has been conceptualized largely on the basis of mouse models [1] . It is viewed as a stepwise process involving apposition and adherence of a blastocyst to the endometrium, followed by breaching of the luminal epithelium and, finally, invasion of maternal tissues. This process seems analogous to an invading cancer, with the embryo driving the destruction of endometrial epithelial cells, the enzymatic digestion of stromal matrix, and finally, the invasion of the maternal decidua and inner myometrium (Fig.  1a) . Within this context, the role of the maternal decidua is to both tolerate and control the invading semiallogeneic fetal trophoblast. Excessive trophoblast invasion of the uterus presents clinically as placenta accreta or choriocarcinoma, conditions associated with considerable maternal morbidity and, occasionally, death. Conversely, inadequate or deregulated invasion of trophoblast compromises the survival of the fetus and causes a spectrum of pregnancy complications, including miscarriage, intrauterine growth restriction, preeclampsia, and stillbirth. Hence, both excessive and inadequate implantation can have disastrous consequences.
Emerging View: Personalized Embryo Implantation
Notwithstanding the complexity at a cellular level, implantation in the conventional paradigm outlined above seems to require little more than a receptive endometrium and an invasive embryo capable of evading maternal immune detection. This may be true for certain species, but recent studies indicate that implantation of a human embryo is much more dynamically controlled by the endometrium than hitherto appreciated. This idea is based on several intertwined observations. First, human endometrial stromal cells (HESCs) have been shown to mount a transient proinflammatory response upon differentiation into decidual cells [2] . These proinflammatory signals trigger the expression of receptivity genes in the overlying surface epithelium and, thus, determine the duration for the window of implantation. Continuous progesterone signaling then drives an anti-inflammatory response essential for postimplantation embryo support. A restricted window of implantation is key to a successful pregnancy, because it ensures that the continuously changing endometrial environment is aligned to meet the requirements of an implanting blastocyst [2] . Second, decidualizing HESCs are highly secretory cells, suggesting that they create the microenvironment and provide the nutrients that enable the conceptus to thrive. Coculture experiments have also shown that decidualizing HESCs are programmed to sense signals from developmentally compromised embryos and then respond by shutting down the secretion of key cytokines and growth factors [3] . Thus, once the luminal epithelium is breached, decidual cells engage in quality control and facilitate maternal rejection of undesirable embryos. Finally, rather than being passive bystanders, decidualizing HESCs have an intrinsic propensity to migrate toward trophoblast [4] [5] [6] . In fact, pioneering work from Helen Mardon and colleagues demonstrated that invasion of human embryonic trophoblast into stromal cell monolayers is blocked upon inhibiting the motility of decidualizing HESCs [5] . In other words, active and directional migration of HESCs in response to local embryonic signals appears to be an integral component of the intense tissue remodeling at the implantation site. Taken together, these emerging concepts suggest that human embryos do not embed in the endometrium randomly but, rather, at receptive sites where stromal cells are poised to encapsulate the conceptus and create a microenvironment tailored to the individual embryo.
Mutual Attraction and Migration
In this issue, Gellersen et al. [4] provide further evidence of mutual attraction between HESCs and trophoblast. Using transwell migration assays, they show that both decidualizing HESCs and trophoblast actively signal to enhance each other's migration. A combination of implantation factors-heparinbinding EGF-like growth factor (HB-EGF), leukemia-inhibitory factor (LIF), and interleukin (IL) 1b-enhanced both directional as well as nondirectional motility of HESCs. In contrast, trophoblast signals only stimulated directional migration, a process known as chemotaxis. This response was attenuated by a neutralizing antibody against plateletderived growth factor AA, a potent chemoattractant secreted by the blastocyst and trophoblast. Chemotaxis in response to trophoblast signals was also blocked upon knockdown of CD82, which-paradoxically, and somewhat controversiallyis a known metastasis suppressor that is highly expressed at the protein but not the mRNA level in decidualizing HESCs. Conversely, Gellersen et al. also show that trophoblast spheroids expand to a greater extent when cultured on a monolayer of decidualized HESCs compared to undifferentiated HESCs, a response that likely is relevant to both the very early stages of the implantation process and the subsequent deep trophoblast invasion. Again, expansion of trophoblast on 
From Migration to Clinical Translation
One should be mindful about the limitations of human implantation models. As exemplified by the study of Gellersen et al., most current model systems are relatively basic, often involve the use of cell lines, and do not include key cells at an implantation site, such as macrophages, uterine natural killer cells, and vascular cells. Nevertheless, concepts such as embryo encapsulation, biosensoring, and mutual trophoblast-decidual cell migration are far from merely academic. They address a fundamental challenge in human reproduction-that is, how can we successfully procreate if pregnancy is based on implantation of one or two deeply invasive and often aneuploidic embryos? Addressing these questions and concepts has shed new light on the mechanisms of pregnancy failure, an area of reproductive medicine that until recently has shown few signs of progress. For example, recent studies indicate that an aberrant decidual response is the hallmark of recurrent miscarriage and is characterized by prolonged expression of proimplantation genes, out-of-phase implantation, and increased sensitivity to oxidative stress [2, 7, 8] . Coculture studies have shown that decidualizing cells respond to the presence of an arresting embryo by inhibiting the secretion of IL1b and HB-EGF [9] , prominent regulators of decidual HESC motility. Taken together, these findings may begin to explain why decidualizing cells from fertile women migrate selectively in vitro to high-quality, but not to low-quality, human embryos [10] . In contrast, decidualizing HESCs from patients with miscarriage were shown to lack this discriminatory capacity and to migrate toward embryos irrespective of embryo quality [10] . Taken together, these observations strongly imply that in contrast to the longstanding dogma of excessive maternal rejection, lack of embryo recognition and selection at implantation predisposes for subsequent clinical pregnancy loss. Finally, these emerging concepts have important therapeutic implications, none more so than interventions aimed at preventing pregnancy complications should begin before conception.
